Roadmap for new opportunities in melanoma research

被引:3
作者
Herlyn, Meenhard [1 ]
Halaban, Ruth [2 ]
Ronai, Ze'ev [3 ]
Schuchter, Lynn [4 ]
Berwick, Marianne [5 ]
Pinkel, Daniel [6 ]
机构
[1] Wistar Inst Anat & Biol, Philadelphia, PA 19104 USA
[2] Yale Univ, Sch Med, Dept Dermatol, New Haven, CT 06510 USA
[3] Burnham Inst, Signal Transduct Program, La Jolla, CA 92037 USA
[4] Univ Penn, Abramson Canc Ctr, Dept Hematol Oncol, Philadelphia, PA USA
[5] Univ New Mexico, Canc Res Facil, Albuquerque, NM USA
[6] Univ Calif San Francisco, Ctr Comprehens Canc, San Francisco, CA 94143 USA
关键词
D O I
10.1053/j.seminoncol.2007.09.004
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Investigators representing all major melanoma research areas present an overview of the most important challenges for the field. Four major research areas are covered plus the training of new investigators. For each area we first describe the present status, its strengths and weaknesses, and then outline specific recommendations. In basic research of melanoma, we outline the pertinent issues for melanoma classification, understanding melanocyte development and transformation, melanoma resistance, tumor microenvironment, metastasis, animal models, immune response, and blood and tissue diagnostics. In clinical research we provide an overview of the current challenges and the strategies for characterization, monitoring, and therapy. It will be important to develop strong research and clinical infrastructures by establishing tumor banks, identifying and validating biomarkers, developing new imaging techniques, and increasing multidisciplinary collaboration and communication. To strengthen the field we need to recruit both young and established investigators and foster career development plans that cover all disciplines. Recent research advances provide significant opportunities to have a major impact on this devastating disease. This group provides recommendations for both short- and long-term strategies that build on research strengths and opportunities established by the many members of the research community.
引用
收藏
页码:566 / 576
页数:11
相关论文
共 53 条
[1]   Gene regulation in melanoma progression by the AP-2 transcription factor [J].
Bar-Eli, M .
PIGMENT CELL RESEARCH, 2001, 14 (02) :78-85
[2]   Atypical Spitz nevi/tumors: Lack of consensus for diagnosis, discrimination from melanoma, and prediction of outcome [J].
Barnhill, RL ;
Argenyi, ZB ;
From, L ;
Glass, LF ;
Maize, JC ;
Mihm, MC ;
Rabkin, MS ;
Ronan, SG ;
White, WL ;
Piepkorn, M .
HUMAN PATHOLOGY, 1999, 30 (05) :513-520
[3]   Spotlight on spotted mice: A review of white spotting mouse mutants and associated human pigmentation disorders [J].
Baxter, LL ;
Hou, L ;
Loftus, SK ;
Pavan, WJ .
PIGMENT CELL RESEARCH, 2004, 17 (03) :215-224
[4]   Semaphorin 3F, a chemorepulsant for endothelial cells, induces a poorly vascularized, encapsulated, nonmetastatic tumor phenotype [J].
Bielenberg, DR ;
Hida, Y ;
Shimizu, A ;
Kaipainen, A ;
Kreuter, M ;
Kim, CC ;
Klagsbrun, M .
JOURNAL OF CLINICAL INVESTIGATION, 2004, 114 (09) :1260-1271
[5]   The genetics of malignant melanoma: Lessons from mouse and man [J].
Chin, L .
NATURE REVIEWS CANCER, 2003, 3 (08) :559-570
[6]   Malignant melanoma: genetics and therapeutics in the genomic era [J].
Chin, Lynda ;
Garraway, Levi A. ;
Fisher, David E. .
GENES & DEVELOPMENT, 2006, 20 (16) :2149-2182
[7]   Ki-67 and p53 expression in minimal deviation melanomas as compared with other nevomelanocytic lesions [J].
Chorny, JA ;
Barr, RJ ;
Kyshtoobayeva, A ;
Jakowatz, J ;
Reed, RJ .
MODERN PATHOLOGY, 2003, 16 (06) :525-529
[8]   Agonist anti-GITR antibody enhances vaccine-induced CD8+ T-cell responses and tumor immunity [J].
Cohen, AD ;
Diab, A ;
Perales, MA ;
Wolchok, JD ;
Rizzuto, G ;
Merghoub, T ;
Huggins, D ;
Liu, CL ;
Turk, MJ ;
Restifo, NP ;
Sakaguchi, S ;
Houghton, AN .
CANCER RESEARCH, 2006, 66 (09) :4904-4912
[9]   The Wnt5A/protein kinase C pathway mediates motility in melanoma cells via the inhibition of metastasis suppressors and initiation of an epithelial to mesenchymal transition [J].
Dissanayake, Samudra K. ;
Wade, Michael ;
Johnson, Carrie E. ;
O'Connell, Michael P. ;
Leotlela, Poloko D. ;
French, Amanda D. ;
Shah, Kavita V. ;
Hewitt, Kyle J. ;
Rosenthal, Devin T. ;
Indig, Fred E. ;
Jiang, Yuan ;
Nickoloff, Brian J. ;
Taub, Dennis D. ;
Trent, Jeffrey M. ;
Moon, Randall T. ;
Bittner, Michael ;
Weeraratna, Ashani T. .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2007, 282 (23) :17259-17271
[10]   The approach to the patient with a difficult melanocytic lesion [J].
Elder, DE ;
Xu, XW .
PATHOLOGY, 2004, 36 (05) :428-434